|1||NCT02740335||Recruiting||Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.||
||370||All||18 Years and older (Adult, Senior)||NCT02740335||LEX-209||June 8, 2017||June 2021||June 2021||April 15, 2016||October 26, 2017||
|Genetic Response to Warfarin in Healthy Subjects||
||35||All||18 Years to 74 Years (Adult, Senior)||NCT01520402||GCO 08-1442
HSM # 11-00577
|June 2009||May 2011||May 2011||January 30, 2012||February 12, 2013||February 7, 2013||
† Study has passed its completion date and status has not been verified in more than two years.